AUD 0.01
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 9.88 Million AUD | -22.03% |
2023 | 12.68 Million AUD | 48.61% |
2022 | 8.53 Million AUD | -49.92% |
2021 | 17.03 Million AUD | 153.63% |
2020 | 6.71 Million AUD | 199.38% |
2019 | 2.24 Million AUD | -85.35% |
2018 | 15.32 Million AUD | -38.94% |
2017 | 25.09 Million AUD | -13.34% |
2016 | 28.95 Million AUD | -22.07% |
2015 | 37.15 Million AUD | 1231.67% |
2014 | 2.78 Million AUD | -23.1% |
2013 | 3.62 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 9.88 Million AUD | -22.03% |
2024 Q2 | 7.22 Million AUD | 0.0% |
2024 Q4 | 9.88 Million AUD | 0.0% |
2023 Q4 | 12.68 Million AUD | 0.0% |
2023 Q2 | 15.37 Million AUD | 0.0% |
2023 FY | 12.68 Million AUD | 48.61% |
2022 Q2 | 12.91 Million AUD | 0.0% |
2022 Q4 | 8.53 Million AUD | 0.0% |
2022 FY | 8.53 Million AUD | -49.92% |
2021 Q2 | 5.57 Million AUD | 0.0% |
2021 Q4 | 17.03 Million AUD | 0.0% |
2021 FY | 17.03 Million AUD | 153.63% |
2020 Q4 | 6.71 Million AUD | 0.0% |
2020 FY | 6.71 Million AUD | 199.38% |
2020 Q2 | 1.95 Million AUD | 0.0% |
2019 Q2 | 5.94 Million AUD | 0.0% |
2019 Q4 | 2.24 Million AUD | 0.0% |
2019 FY | 2.24 Million AUD | -85.35% |
2018 FY | 15.32 Million AUD | -38.94% |
2018 Q4 | 15.32 Million AUD | 0.0% |
2018 Q2 | 18.76 Million AUD | 0.0% |
2017 Q4 | 25.09 Million AUD | 0.0% |
2017 FY | 25.09 Million AUD | -13.34% |
2017 Q2 | 32.04 Million AUD | 0.0% |
2016 FY | 28.95 Million AUD | -22.07% |
2015 FY | 37.15 Million AUD | 1231.67% |
2014 FY | 2.78 Million AUD | -23.1% |
2013 FY | 3.62 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 91.762% |
Aroa Biosurgery Limited | 101.82 Million AUD | 90.29% |
Atomo Diagnostics Limited | 11.37 Million AUD | 13.111% |
Anteris Technologies Ltd | 45.7 Million AUD | 78.366% |
Control Bionics Limited | 9.02 Million AUD | -9.525% |
CardieX Limited | 12.64 Million AUD | 21.839% |
Compumedics Limited | 40.35 Million AUD | 75.501% |
Cochlear Limited | 2.74 Billion AUD | 99.64% |
CleanSpace Holdings Limited | 26.05 Million AUD | 62.048% |
Cyclopharm Limited | 45.91 Million AUD | 78.466% |
EMVision Medical Devices Ltd | 23.97 Million AUD | 58.754% |
Nova Eye Medical Limited | 29.88 Million AUD | 66.913% |
HeraMED Limited | 2.95 Million AUD | -234.92% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | 18.798% |
ImpediMed Limited | 46.98 Million AUD | 78.957% |
InhaleRx Limited | 1.57 Million AUD | -527.006% |
LBT Innovations Limited | 7.93 Million AUD | -24.665% |
Micro-X Limited | 26.89 Million AUD | 63.238% |
Neurotech International Limited | 12.21 Million AUD | 19.047% |
OncoSil Medical Limited | 6.71 Million AUD | -47.165% |
PolyNovo Limited | 109.16 Million AUD | 90.943% |
Respiri Limited | 6.19 Million AUD | -59.704% |
SomnoMed Limited | 69.8 Million AUD | 85.836% |
Universal Biosensors, Inc. | 30.12 Million AUD | 67.175% |
Uscom Limited | 5.13 Million AUD | -92.558% |
Visioneering Technologies, Inc. | 11.2 Million AUD | 11.764% |